| (Values in U.S. Thousands) | Jun, 2016 | Mar, 2016 | Dec, 2015 | Sep, 2015 | Jun, 2015 |
| Sales | -9,999,000 | 14,120 | 14,080 | 11,390 | 8,620 |
| Sales Growth | -70,914.45% | +0.28% | +23.62% | +32.13% | +21.92% |
| Net Income | -9,999,000 | -14,560 | -13,360 | -24,060 | -24,480 |
| Net Income Growth | -68,574.45% | -8.98% | +44.47% | +1.72% | -19.94% |
Xenoport (XNPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of existing drugs.
Fiscal Year End Date: 12/31